Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development. Clin Cancer Res. 2007 Mar 15; 13(6):1630-3.